Bond Screener
Kedrion
LEI 81560047FA58E1BEDF67
Organization name
Kedrion SPA
Country name
Italy
Country of registration
Italy
Industry
Medical Devices
Credit Ratings
in foreign currency
Public debt
2,370 mln USD
Upgrade to Premium features
Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market
Get access
-
Full access to the largest bond database
Bond parameters,
prospectuses -
Seamless
Data exportAnalyze the data in the most efficient way
-
Bond pricing
Current & historical quotes from 400+ stock exchanges & OTC market
-
Smart risk assessment
Credit ratings, financial reports
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Kedrion SPA (formerly Kedrion Group SPA) is an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products for use in treating serious diseases, disorders and conditions such as hemophilia and immune system deficiencies.
Kedrion was established in Italy in 2001, but the roots of the companies from which it was born stretch back several decades in the production of blood and plasma derived products. A primarily family-owned business, it places a high value not only on the welfare of those who benefit from its products but on the people and communities where it operates.
|
General information
-
Organization nameKedrion SPA
-
Organization statusOperating organization
-
Site
-
IR Site
News
IFRS/US GAAP reports
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
Show all
Hide
Authorization required
You need to request access
